Research on L-glutamine for gut health shows promising results, though specific studies with GLP-1 medications remain limited
The commercial success of any weight loss therapeutic will depend heavily on patient acceptability and adherence, making oral, long-acting depot, and other non-injectable options critical pipeline priorities rather than nice-to-have features
To understand what brenipatide is, you need to understand why obesity was always going to be the easy part
While the FDA has not yet approved retatrutide, we recommend consulting with a healthcare provider or our team of experts at the biostation if it's something you're interested in learning more about
If you experience any severe symptoms outside of minor swelling or bruising at the injection site, including significant pain at the injection site that has not gone away by the next day, call your doctor immediately.
In short: Lilly is likely unwilling to cannibalize its injectables franchise
